IDH1 and central nervous system cancer: The decision tree classifier predicted the highest possibility rate of short post-surgical survival time for the glioma patients with the combination of IDH1 wild-type genotype, lower miR-181d tumoral expression, higher miR-181b tumoral expression, and weaker tumor related symptoms.